These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6644427)

  • 1. Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia.
    Buchanan GR; Bowman WP; Smith SJ
    J Pediatr; 1983 Dec; 103(6):921-3. PubMed ID: 6644427
    [No Abstract]   [Full Text] [Related]  

  • 2. Less intensive long-term transfusion therapy for sickle cell anemia and cerebrovascular accident.
    Miller ST; Jensen D; Rao SP
    J Pediatr; 1992 Jan; 120(1):54-7. PubMed ID: 1731025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease.
    Russell MO; Goldberg HI; Hodson A; Kim HC; Halus J; Reivich M; Schwartz E
    Blood; 1984 Jan; 63(1):162-9. PubMed ID: 6689947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after transition to an adult program.
    McLaughlin JF; Ballas SK
    Transfusion; 2016 May; 56(5):1014-21. PubMed ID: 26593779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransfusion crises in sickle cell anemia: role of delayed hemolytic reactions to transfusion.
    Milner PF; Squires JE; Larison PJ; Charles WT; Krauss JS
    South Med J; 1985 Dec; 78(12):1462-9. PubMed ID: 4071176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.
    Adams RJ; McKie VC; Hsu L; Files B; Vichinsky E; Pegelow C; Abboud M; Gallagher D; Kutlar A; Nichols FT; Bonds DR; Brambilla D
    N Engl J Med; 1998 Jul; 339(1):5-11. PubMed ID: 9647873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic phagocytic function in children with sickle cell anemia receiving long-term hypertransfusion therapy.
    Buchanan GR; McKie V; Jackson EA; Vedro DA; Hamner S; Holtkamp CA
    J Pediatr; 1989 Oct; 115(4):568-72. PubMed ID: 2795347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased blood requirements during long-term transfusion therapy for sickle cell disease.
    Cohen AR; Buchanan GR; Martin M; Ohene-Frempong K
    J Pediatr; 1991 Mar; 118(3):405-7. PubMed ID: 1999779
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of total hemoglobin and hemoglobin S concentration on cerebral blood flow during transfusion therapy to prevent stroke in sickle cell disease.
    Hurlet-Jensen AM; Prohovnik I; Pavlakis SG; Piomelli S
    Stroke; 1994 Aug; 25(8):1688-92. PubMed ID: 8042222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined blood transfusion and hydroxycarbamide in children with sickle cell anaemia.
    Brousse V; Gandhi S; de Montalembert M; Height S; Dick MC; O'Driscoll S; Abihsera G; Rees DC
    Br J Haematol; 2013 Jan; 160(2):259-61. PubMed ID: 23116405
    [No Abstract]   [Full Text] [Related]  

  • 11. [Transfusion in sickle cell anemia].
    Bachir D; Bonnet-Gajdos M; Galacteros F
    Presse Med; 1990 Oct; 19(35):1627-31. PubMed ID: 2147256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease.
    Wang WC; Kovnar EH; Tonkin IL; Mulhern RK; Langston JW; Day SW; Schell MJ; Wilimas JA
    J Pediatr; 1991 Mar; 118(3):377-82. PubMed ID: 1999776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic transfusion practice for children with sickle cell anaemia and stroke.
    Aygun B; McMurray MA; Schultz WH; Kwiatkowski JL; Hilliard L; Alvarez O; Heeney M; Kalinyak K; Lee MT; Miller S; Helms RW; Ware RE;
    Br J Haematol; 2009 May; 145(4):524-8. PubMed ID: 19344396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques for blood administration in sickle cell patients.
    Eckman JR
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):23-9. PubMed ID: 11206958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic quiz case: a 16-year-old adolescent girl with a trace level of hemoglobin s detected by high-performance liquid chromatography. Almost complete suppression of hemoglobin S in a sickle cell disease patient undergoing long-term transfusion therapy.
    Scurlock D; Risin SA
    Arch Pathol Lab Med; 2005 Apr; 129(4):e107-8. PubMed ID: 15794693
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular effects of hypertransfusion therapy in children with sickle cell anemia.
    Lester LA; Sodt PC; Hutcheon N; Arcilla RA
    Pediatr Cardiol; 1990 Jul; 11(3):131-7. PubMed ID: 2144343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke.
    Rana S; Houston PE; Surana N; Shalaby-Rana EI; Castro OL
    J Pediatr; 1997 Nov; 131(5):757-60. PubMed ID: 9403661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia.
    Bishop S; Matheus MG; Abboud MR; Cane ID; Adams RJ; Jackson SM; Kalpatthi R
    Blood Cells Mol Dis; 2011 Aug; 47(2):125-8. PubMed ID: 21724428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term management of splenic sequestration in children with sickle cell disease.
    Kinney TR; Ware RE; Schultz WH; Filston HC
    J Pediatr; 1990 Aug; 117(2 Pt 1):194-9. PubMed ID: 2380816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.
    Miller ST; Wright E; Abboud M; Berman B; Files B; Scher CD; Styles L; Adams RJ;
    J Pediatr; 2001 Dec; 139(6):785-9. PubMed ID: 11743502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.